Clinical Trials on Reduced Mortality in New Zealand

Total 1542 results

New York State Psychiatric Institute

Terminated

Cannabinoids for Taxane Induced Peripheral Neuropathy

Chemotherapy-induced Peripheral Neuropathy

United States
Columbia University
National Institute on Drug Abuse (NIDA); New York University; Beth Israel Medical...

Completed

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results (iKnow2 Project)

Substance-related Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effect of Quetiapine on Marijuana Withdrawal and Relapse

Marijuana Smoking

United States
Addex Pharma S.A.

Recruiting

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
Botec Analysis, LLC

Unknown

An Evaluation of the NJSPB SCF Project for Opioid-Involved High-Risk Parolees

Substance Abuse | Criminal Behavior

United States
Yasmin Hurd

Recruiting

Cannabidiol for Opioid Addiction

Opioid Use Disorder

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Recruiting

Targeting Drug Memories With Methylphenidate

Substance Use Disorder | Cocaine Use Disorder

United States
NYU Langone Health

Recruiting

Electronic Cigarettes as a Harm Reduction Strategy in Individuals With Substance Use Disorder

Addiction | Cigarette Smoking | E Cig Use

United States
Yasmin Hurd

Completed

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder

United States
New York State Psychiatric Institute

Suspended

A Study of SPG Block for Opioid Withdrawal

Opioid Use Disorder

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Withdrawn

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study (NT-814)

Opioid Use Disorder

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); VA Connecticut Healthcare System

Completed

Pharmacotherapy for Schizophrenic Drug Users - 6

Substance-Related Disorders | Cocaine-Related Disorders | Shcizophrenia

United States
State University of New York at Buffalo

Completed

An Exercise App to Reduce Young Adults' MJ Use

Marijuana Smoking

United States
Oregon Research Institute

Recruiting

Adolescent Screening and Personalized Intervention Resource for Enhancement of Behavioral Health and Substance Use (ASPIRE)

Substance Use | Mental Health Issue

United States
University of Rochester
National Institute on Drug Abuse (NIDA)

Completed

The Association Between Loneliness and Substance Use

Loneliness | Opioid Use

United States
The Mind Research Network

Terminated

Mechanisms of Lorcaserin for Smoking Cessation

Smoking Cessation | Tobacco Use Disorder

United States
University of New Mexico
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Providing Expanded Continuous Labor Support to Pregnant Women in New Mexico With Substance Use Disorders (Project_SuM)

Pregnancy Related | Substance Use Disorders

United States
University of New Mexico
National Institute on Drug Abuse (NIDA)

Completed

Testing Effectiveness of the Community Reinforcement Approach and Family Training (CRAFT) With American Indians (CRAFT-AI)

Substance Use Disorders | Family Members

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Functional Magnetic Resonance Imaging of N-acetylcysteine in Cocaine Dependence

Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); US Department of Veterans Affairs

Completed

GABA (Gamma Amino Butyric Acid) Medication for Tobacco

Nicotine Dependence

United States
The Mind Research Network
National Institute on Drug Abuse (NIDA)

Completed

TDCS and Cognitive Retraining to Augment Pharmacotherapy for the Treatment of Nicotine Dependence (TDCSNIC)

Nicotine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); APT Foundation, Inc.

Completed

Automated Recovery Line for Medication Assisted Treatment

Substance Use Disorders | Drug Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

CBT With Disulfiram and Contingency Management

Cocaine Abuse

United States
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Trial of Modafinil for Methamphetamine Dependence

Amphetamine Dependence

Australia
The University of New South Wales
St Vincent's Hospital, Sydney; Australian Government Department of Health and... and other collaborators

Unknown

Randomised Placebo-Controlled Trial of Modafinil for Cocaine Dependence

Cocaine Dependence

Australia
Evangelic Hospital Kalk Cologne

Completed

Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease

Anxiety Disorders | GERD - Gastro-Esophageal Reflux Disease

Germany
Rutgers, The State University of New Jersey
National Institute on Drug Abuse (NIDA)

Completed

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI) (PTSC-S)

Schizophrenia | Schizoaffective Disorder | Tobacco Use | Tobacco Smoking | Tobacco Use Disorder | Tobacco Use Cessation

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
University of Arizona
Carrier Clinic

Active, not recruiting

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

Depression | Insomnia | Anxiety | Substance Abuse

United States
BioXcel Therapeutics Inc
Cognitive Research Corporation

Completed

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal (RELEASE)

Opioid Withdrawal

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Patient Feedback Effectiveness Study

Substance Use Disorders

United States
NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Recruiting

Black Church Treatment Study

Alcohol Use Disorder

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA)

Completed

Aprepitant Effects in Intravenous Heroin Dependence

Opioid Dependence

United States
Hurd,Yasmin, Ph.D.

Completed

Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

Opiate Addiction

United States
Research Foundation for Mental Hygiene, Inc.

Completed

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Alcohol Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
NYU Langone Health
NYC Health + Hospitals

Completed

XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept

Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial

Opioid-Related Disorders | Heroin Dependence

United States
New York State Psychiatric Institute
Omeros Corporation

Completed

Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone

Opioid Abuse

United States
Northwell Health

Completed

Project Motion, A Study of Motivational Interviewing to Reduce Heavy or Problematic Drinking

Alcohol Dependence | Alcohol Abuse

United States
Hunter College of City University of New York

Completed

Risk Reduction Intervention for Vulnerable Young Adult Males (YMHP)

HIV | Substance Use | Sex

United States
Research Foundation for Mental Hygiene, Inc.

Unknown

Medication and Counseling for Controlled Drinking (ProjectSMART)

Alcohol Dependence | Alcohol Abuse

United States
AstraZeneca

Completed

Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms (C27)

GERD | Heartburn | Acid Reflux Disease | Regurgitation

United States
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)

Completed

Addressing Substance Use Through CVCT

Drug Use | Sex, Unsafe

United States
Icahn School of Medicine at Mount Sinai
National Institute on Drug Abuse (NIDA)

Completed

Integrated Care (iCare) at Mount Sinai to Improve Substance Use Diagnosis and Treatment Practices in HIV Clinic Settings

Substance Abuse

United States
Columbia Care Inc.

Completed

Pharmacogenetic Variation: Factors That May Affect the Efficacy and Safety of Medical Marijuana

New York Medical Marijuana Program Qualifying Conditions

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 (VEN)

Depression | Marijuana Abuse

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Memantine as a Supplement to Naltrexone in Treating Heroin Dependence (NAMHS)

Heroin Dependence | Opioid Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone (Depot-BNT)

Heroin Dependence | Opiate Dependence

United States

Clinical Trials on Reduced Mortality in New Zealand

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations